CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells

W Yu, Q Zhang, Y Qiu, H Chen, X Huang… - Clinical and …, 2023 - Taylor & Francis
ABSTRACT Background and Purpose Substitution of Cys674 (C674) in the sarcoplasmic/
endoplasmic reticulum Ca2+ ATPase 2 (SERCA2) causes SERCA2 dysfunction which leads …
被引用次数：2 相关文章

CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells.

W Yu, Q Zhang, Y Qiu, H Chen, X Huang… - … (New York, NY: 1993 …, 2023 - europepmc.org
Background and purpose Substitution of Cys 674 (C674) in the sarcoplasmic/endoplasmic
reticulum Ca 2+ ATPase 2 (SERCA2) causes SERCA2 dysfunction which leads to activated …

CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cells

W Yu, Q Zhang, Y Qiu, H Chen… - … (New York, NY …, 2023 - pubmed.ncbi.nlm.nih.gov
Background and purpose Substitution of Cys 674 (C674) in the sarcoplasmic/endoplasmic
reticulum Ca 2+ ATPase 2 (SERCA2) causes SERCA2 dysfunction which leads to activated …